Enhanced antitumor efficacy of nanostructured lipid carrier co-loaded with docetaxel and 5-fluorouracil for targeted gastric cancer therapy
- 22 January 2025
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 42 (2) , 1-15
Abstract
This study presents nanostructured lipid carrier (NLC) co-loaded with Docetaxel (DCT) and 5-Fluorouracil (5-FU) as a targeted therapeutic approach for gastric cancer (GC). Using nanoprecipitation, NLC-DCT/5-FU were synthesized and exhibited an average particle size of 215.3 ± 10.4 nm, a polydispersity index (PDI) of 0.29, and a zeta potential of − 17.1 mV. Encapsulation efficiency reached 95.9% for DCT and 5-FU, with a loading efficiency of 11.2%. In vitro release studies demonstrated a biphasic release profile, with an initial burst and sustained release, achieving 85.6% DCT and 75.8% 5-FU release over 72 h. Cytotoxicity assays in MKN45 cells showed a significantly lower half-maximal inhibitory concentration (IC50) for NLC-DCT/5-FU (0.3 µM) compared to free DCT (3.9 µM) and free 5-FU (19.5 µM), indicating enhanced efficacy. In vivo evaluation in a GC mouse model confirmed substantial tumor volume reduction to 213 mm3 with NLC-DCT/5-FU treatment, compared to 432 mm3 with the free-drug combination. Systemic safety assessment showed minimal adverse effects, suggesting the nanoparticles’ enhanced therapeutic index. These results demonstrate that NLC-based co-delivery systems could substantially improve the clinical outcomes of GC therapy.Keywords
Funding Information
- Princess Nourah Bint Abdulrahman University (PNURSP2024R386)
This publication has 49 references indexed in Scilit:
- Nanoparticle-integrated metal–organic frameworks: a revolution in next-generation drug delivery systemsJournal of Pharmaceutical Investigation, 2024
- Developing Engineered Nano-Immunopotentiators for the Stimulation of Dendritic Cells and Inhibition and Prevention of MelanomaPharmaceutical Research, 2024
- Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumorsBioactive Materials, 2024
- Overcoming biological barriers BBB/BBTB by designing PUFA functionalised lipid-based nanocarriers for glioblastoma targeted therapyMaterials Science and Engineering: C, 2023
- 5-Fluorouracil loaded magnetic cellulose bionanocomposites for potential colorectal cancer treatmentCarbohydrate Polymers, 2021
- A resveratrol-loaded nanostructured lipid carrier hydrogel to enhance the anti-UV irradiation and anti-oxidant efficacyColloids and Surfaces B: Biointerfaces, 2021
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastomaTumor Biology, 2014
- An Investigation into the Parameters Affecting Preparation of Polybutyl Cyanoacrylate Nanoparticles by Emulsion PolymerizationIndian Journal of Clinical Biochemistry, 2013
- In Vitro Evaluation of the Efficacy of Liposomal and Pegylated Liposomal HydroxyureaIndian Journal of Clinical Biochemistry, 2013